4-123028199-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_145207.3(AFG2A):c.1883A>G(p.Asp628Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000753 in 1,461,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_145207.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA5 | ENST00000274008.5 | c.1883A>G | p.Asp628Gly | missense_variant | Exon 11 of 16 | 1 | NM_145207.3 | ENSP00000274008.3 | ||
SPATA5 | ENST00000422835.2 | n.1925A>G | non_coding_transcript_exon_variant | Exon 11 of 15 | 1 | |||||
SPATA5 | ENST00000675612.1 | c.1952A>G | p.Asp651Gly | missense_variant | Exon 12 of 17 | ENSP00000502453.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251348Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135854
GnomAD4 exome AF: 0.0000753 AC: 110AN: 1461786Hom.: 0 Cov.: 31 AF XY: 0.0000729 AC XY: 53AN XY: 727192
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:5
The p.D628G variant in the SPATA5 gene has not been reported previously as a disease-causing mutation nor as a benign polymorphism, to our knowledge. This variant concerns an evolutionary strongly conserved amino acid. Predictions suggest a pathogenic effect. It was found in the compound heterozygous state together with the p.Y559* mutation. The p.D628G variant was observed at an allele frequency of 0.00006 in approximately 33.000 individuals of European ancestry (ExAC database), indicating it is not a common benign variant in these populations. We interpret p.D628G as a likely pathogenic variant. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26299366, 29343804, 27535533, 35354024) -
- -
- -
- -
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Pathogenic:4
- -
Variant summary: AFG2A c.1883A>G (p.Asp628Gly) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251348 control chromosomes. c.1883A>G has been reported in the literature in the compound heterozygous state in individuals affected with and/or with some clinical features of Epilepsy, Hearing Loss, And Mental Retardation Syndrome who underwent whole exome sequencing, including cases where it has been confirmed to be in trans with a pathogenic variant and has segregated with disease in at least one family (e.g. Tanaka_2015, Moreno-De-Luca_2021, Koh_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 37471090, 33528536, 26299366). ClinVar contains an entry for this variant (Variation ID: 203524). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 628 of the SPATA5 protein (p.Asp628Gly). This variant is present in population databases (rs768528444, gnomAD 0.007%). This missense change has been observed in individual(s) with SPATA5-related conditions (PMID: 26299366; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 203524). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SPATA5 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at